The American Association for Cancer Research (AACR) is accepting submissions of ideas for the Stand Up To Cancer–Ovarian Cancer Research Fund–Ovarian Cancer National Alliance–National Ovarian Cancer Coalition (SU2C-OCRF-OCNA-NOCC) Translational Research Dream Team Grant that will offer up to $6 million in research funding.
The Translational Research Dream Team grant provides 3 years of funding for research projects that must include therapeutic interventions for ovarian cancer and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional team of experts. Proposals for the grant must describe plans indicating how the group will use a transformative and synergistic approach, and how the work will be translated into the clinic. To maximize creativity, innovation, and collaboration, the projects should span multiple disciplines and use modern scientific tools to attack research questions in a coordinated effort.
Advisory Committee
A Joint Scientific Advisory Committee appointed by the involved organizations will conduct a unique, interactive, rapid, and rigorous evaluation of the applications via a multistep scientific review process. The committee is comprised of senior laboratory researchers and physician-scientists, as well as advocates.
The committee is chaired by Arnold J. Levine, PhD, Professor at the Institute for Advanced Study in Princeton, and at the Cancer Institute of New Jersey in New Brunswick. William G. Nelson, MD, PhD, Director of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, and Jeff Boyd, PhD, Senior Vice President at the Fox Chase Cancer Center in Philadelphia and Chair of OCRF’s Scientific Advisory Committee, will serve as Vice Chairs.
Letters of Intent for the SU2C-OCRF-OCNA-NOCC Translational Research Dream Team Grant are due by November 7, 2014. For more information visit http://www.aacr.org/Pages/Home.aspx. ■
